Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 17401-17450 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02911571
PRospective Multiple Myeloma Impact Study
NA
Active, not recruiting
250 participants
Started: Feb 27, 2018 · Completed: Sep 1, 2026
1 condition
2 sponsors
9 locations
NCT03449953
Critical Care Outcomes of Hematologic Oncology Patients
N/A
Active, not recruiting
415 participants
Started: Feb 26, 2018 · Completed: Dec 31, 2026
2 conditions
1 sponsor
13 locations
NCT03444454
Telerehabilitation in Multiple Sclerosis
NA
Active, not recruiting
136 participants
Started: Feb 26, 2018 · Completed: Jun 30, 2024
1 condition
6 sponsors
1 location
NCT03460067
Omission of Radiation in Patients With Her-2 Positive Breast Cancer
NA
Active, not recruiting
12 participants
Started: Feb 23, 2018 · Completed: Jul 16, 2027
1 condition
1 sponsor
1 location
NCT03405792
Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
PHASE2
Active, not recruiting
40 participants
Started: Feb 23, 2018 · Completed: Sep 30, 2025
2 conditions
2 sponsors
1 location
NCT03391362
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
NA
Active, not recruiting
100 participants
Started: Feb 23, 2018 · Completed: Feb 1, 2026
2 conditions
1 sponsor
1 location
NCT03432949
Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC
PHASE4
Active, not recruiting
24 participants
Started: Feb 23, 2018 · Completed: Jul 30, 2024
1 condition
2 sponsors
1 location
NCT03464305
ASPIRIN Trial Belgium
PHASE3
Active, not recruiting
148 participants
Started: Feb 22, 2018 · Completed: Dec 31, 2027
1 condition
3 sponsors
29 locations
NCT04195139
Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
PHASE2
Active, not recruiting
103 participants
Started: Feb 22, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
20 locations
NCT03092011
Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
PHASE4
Active, not recruiting
69 participants
Started: Feb 21, 2018 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT03631693
Imaging Analysis Following Periodontal Surgery
NA
Active, not recruiting
60 participants
Started: Feb 21, 2018 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03525418
Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)
PHASE1/PHASE2
Active, not recruiting
10 participants
Started: Feb 21, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
5 locations
NCT03299426
Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi
PHASE3
Active, not recruiting
30,000 participants
Started: Feb 21, 2018 · Completed: Oct 30, 2025
1 condition
5 sponsors
1 location
NCT03436368
Continuous Spinal Anesthesia in Renal Transplantation
NA
Active, not recruiting
60 participants
Started: Feb 20, 2018 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT03128268
The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works
NA
Active, not recruiting
250 participants
Started: Feb 20, 2018 · Completed: Jun 20, 2023
1 condition
3 sponsors
1 location
NCT03421132
Multiple Myeloma Molecular Monitoring Study
N/A
Active, not recruiting
96 participants
Started: Feb 20, 2018 · Completed: Mar 31, 2026
1 condition
1 sponsor
9 locations
NCT03198026
Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas
PHASE2
Active, not recruiting
30 participants
Started: Feb 20, 2018 · Completed: Feb 20, 2032
19 conditions
3 sponsors
1 location
NCT03532360
Peanut and Tree Nut Desensitization
NA
Active, not recruiting
51 participants
Started: Feb 19, 2018 · Completed: Dec 31, 2027
2 conditions
2 sponsors
2 locations
NCT03285152
A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients
NA
Active, not recruiting
19 participants
Started: Feb 19, 2018 · Completed: Aug 11, 2026
1 condition
3 sponsors
8 locations
NCT03384914
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
PHASE2
Active, not recruiting
119 participants
Started: Feb 19, 2018 · Completed: Dec 31, 2027
8 conditions
2 sponsors
7 locations
NCT03437616
Cardiovascular Rehabilitation - Effectiveness of the Tulppa Program
NA
Active, not recruiting
300 participants
Started: Feb 19, 2018 · Completed: Dec 31, 2029
1 condition
2 sponsors
1 location
NCT03395522
Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH
NA
Active, not recruiting
149 participants
Started: Feb 18, 2018 · Completed: Apr 25, 2025
1 condition
1 sponsor
12 locations
NCT03491059
Feasibility of PET/CT to Detect the Oral/Pulmonary Distribution of Nicotine Following E-cigarette Use
PHASE4
Active, not recruiting
2 participants
Started: Feb 16, 2018 · Completed: Feb 16, 2025
1 condition
1 sponsor
1 location
NCT03431181
Optimal VAsopressor TitraTION in Patients 65 Years and Older
NA
Active, not recruiting
159 participants
Started: Feb 16, 2018 · Completed: Dec 31, 2024
4 conditions
1 sponsor
1 location
NCT03441295
LIBRE (Ligamys, Internal Bracing, REconstruction) Study: Comparing Three Surgery Techniques After an Acute ACL Rupture.
NA
Active, not recruiting
95 participants
Started: Feb 15, 2018 · Completed: Aug 30, 2025
1 condition
3 sponsors
3 locations
NCT03375437
RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.
NA
Active, not recruiting
376 participants
Started: Feb 15, 2018 · Completed: Dec 15, 2025
3 conditions
2 sponsors
10 locations
NCT03138564
An Effectiveness-Implementation Trial of SPIRIT in ESRD
NA
Active, not recruiting
852 participants
Started: Feb 15, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
39 locations
NCT03426748
LDR vs. HDR Brachytherapy for Prostate Cancer
NA
Active, not recruiting
140 participants
Started: Feb 15, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04009421
Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease
N/A
Active, not recruiting
1,400 participants
Started: Feb 15, 2018 · Completed: Dec 31, 2028
2 conditions
2 sponsors
1 location
NCT03441061
Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
PHASE2
Active, not recruiting
40 participants
Started: Feb 15, 2018 · Completed: Feb 28, 2027
3 conditions
2 sponsors
1 location
NCT03741582
Urban Transformations and Health: the Case of TransMiCable in Bogotá
N/A
Active, not recruiting
2,052 participants
Started: Feb 15, 2018 · Completed: Jun 1, 2025
6 conditions
4 sponsors
1 location
NCT03217422
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade
PHASE2/PHASE3
Active, not recruiting
68 participants
Started: Feb 15, 2018 · Completed: Dec 25, 2025
1 condition
1 sponsor
28 locations
NCT03389347
High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
NA
Active, not recruiting
40 participants
Started: Feb 14, 2018 · Completed: Dec 19, 2026
3 conditions
1 sponsor
1 location
NCT03394612
Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children
PHASE2
Active, not recruiting
20 participants
Started: Feb 14, 2018 · Completed: Dec 31, 2026
1 condition
6 sponsors
7 locations
NCT03178617
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
NA
Active, not recruiting
214 participants
Started: Feb 14, 2018 · Completed: Nov 28, 2025
4 conditions
2 sponsors
3 locations
NCT03467191
Behavioral Alcohol Responses (BAR) Study
EARLY_PHASE1
Active, not recruiting
782 participants
Started: Feb 13, 2018 · Completed: Oct 31, 2025
6 conditions
4 sponsors
1 location
NCT03282656
Gene Transfer for Sickle Cell Disease
PHASE1
Active, not recruiting
10 participants
Started: Feb 13, 2018 · Completed: Dec 13, 2024
1 condition
1 sponsor
2 locations
NCT03445936
PRELOOP Trial: Synthetic Versus Biological Mesh for Prevention of Incisional Hernia After Loop-ileostomy Closure
NA
Active, not recruiting
100 participants
Started: Feb 13, 2018 · Completed: Oct 31, 2027
1 condition
1 sponsor
4 locations
NCT03217786
Early Post Transplant Cardiac Allograft Vasculopathy
N/A
Active, not recruiting
80 participants
Started: Feb 12, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03413800
Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant
PHASE2
Active, not recruiting
10 participants
Started: Feb 12, 2018 · Completed: Jan 1, 2026
2 conditions
3 sponsors
1 location
NCT03029403
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
PHASE2
Active, not recruiting
47 participants
Started: Feb 12, 2018 · Completed: Apr 12, 2026
4 conditions
3 sponsors
1 location
NCT03400332
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
PHASE1/PHASE2
Active, not recruiting
281 participants
Started: Feb 12, 2018 · Completed: Nov 30, 2025
2 conditions
1 sponsor
72 locations
NCT03437681
Tissue-specific Effects of Insufficient Sleep
NA
Active, not recruiting
18 participants
Started: Feb 12, 2018 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT03225547
Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer
PHASE2
Active, not recruiting
74 participants
Started: Feb 12, 2018 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT04481087
Clinical Comparison of Different Adhesives in NCCLs
NA
Active, not recruiting
34 participants
Started: Feb 10, 2018 · Completed: Jun 10, 2026
1 condition
1 sponsor
1 location
NCT03319485
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease
NA
Active, not recruiting
92 participants
Started: Feb 9, 2018 · Completed: Jan 31, 2025
1 condition
1 sponsor
20 locations
NCT03423199
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
PHASE3
Active, not recruiting
180 participants
Started: Feb 9, 2018 · Completed: Sep 30, 2025
1 condition
3 sponsors
23 locations
NCT03301441
Sensitivity to Acute Cerebral Ischemia in Migrainers
N/A
Active, not recruiting
605 participants
Started: Feb 9, 2018 · Completed: Jul 31, 2024
3 conditions
1 sponsor
1 location
NCT03410875
A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
PHASE2
Active, not recruiting
30 participants
Started: Feb 9, 2018 · Completed: Jan 31, 2026
3 conditions
3 sponsors
9 locations
NCT03147612
Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
PHASE2
Active, not recruiting
22 participants
Started: Feb 8, 2018 · Completed: Feb 28, 2027
6 conditions
1 sponsor
1 location
Previous
1
More pages
346
347
348
349
350
351
352
More pages
431
Next